Samuel David
25Patents
4h-index
47Co-inventors
63Inventor score
Filing activity: Aug 22, 1977 → Jul 20, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7241770B2 | Hydronopol derivatives as agonists on human ORL1 receptors | Human Necessities | 15 | Expired |
| US4391819A | 2,9-Dioxa tricyclo [4,3,1,0.sup.3,7 ] decane compounds and process of making same | Chemistry; Metallurgy | 8 | Expired |
| US7238470B2 | Method of treating or inhibiting obesity | Physics | 8 | Expired |
| US5294638A | Phenyalkylaminoalkyl compounds and pharmaceutical compositions containing them | Chemistry; Metallurgy | 6 | Expired |
| US7851630B2 | Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors | Chemistry; Metallurgy | 3 | Active |
| US5438068A | Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds | Human Necessities | 3 | Expired |
| US4182889A | Process for preparing 10-methyl-2,9-dioxatricyclo[4,3,1,0.sup.3,7 ] decanes | Chemistry; Metallurgy | 3 | Expired |
| US4158061A | 2,9-Dioxatricyclo[4,3,1,0.sup.3,7 ] decane derivatives, processes for their preparation and pharmaceutical compositions thereof | Chemistry; Metallurgy | 3 | Expired |
| US4980487A | Novel valepotriate hydrin containing medicines | Human Necessities | 2 | Expired |
| US6946243B2 | Method of identifying compounds suitable for treatment and/or prophylaxis of obesity | Physics | 2 | Expired |
| US4117148A | 2,9-Dioxatricyclo [4,3,1,0,3,7] decane derivatives, processes for their preparation and pharmaceutical compositions thereof | Chemistry; Metallurgy | 2 | Expired |
| US5212173A | Alkylaminoalkylamine and ether compounds, processes and intermediates for their preparation, and medicaments containing them | Chemistry; Metallurgy | 2 | Expired |
| US6001833A | Urea derivatives | Emerging Cross-Sectional Technologies | 2 | Expired |
| US4141988A | 2,9-Dioxatricyclo[4,3,1,0.sup.3,7 ]decane derivatives, processes for their preparation and pharmaceutical compositions thereof | Human Necessities | 2 | Expired |
| US4207331A | 2,9-Dioxatricyclo[4,3,1,0.sup.3,7 ]decane derivatives and pharmaceutical compositions thereof | Chemistry; Metallurgy | 1 | Expired |
| US6770649B2 | 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them | Chemistry; Metallurgy | 1 | Expired |
| US9050294B2 | Treatment of neural diseases or conditions | Human Necessities | 0 | Active |
| US8642658B2 | Treatment of neural diseases or conditions | Human Necessities | 0 | Active |
| US4714709A | N-(2,10-dioxa-tricyclo-[5,3,1,0.sup.3,8 ]-undecane-5-yl)-tryptamine derivatives and medical compositions thereof | Human Necessities | 0 | Expired |
| US7282325B2 | Method of preparing pharmaceutical compositions | Physics | 0 | Expired |
| US8759392B2 | Amides as inhibitors of human secreted phospholipase A2 | Chemistry; Metallurgy | 0 | Active |
| US6040303A | 7-phenyl-1, 4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11583511B2 | Maresins for use in the treatment of CNS injuries | Emerging Cross-Sectional Technologies | 0 | Active |
| US4891384A | Valepotriate hydrin containing medicines used to treat uclers and motility disturbances | Human Necessities | 0 | Expired |
| US8420852B2 | Phospholipase A2 inhibitors and their use in treating neurological injury and disease | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.